Stock comparison

BIIBvsVRTX

Biogen IncvsVertex Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

BIIB

Biogen Inc

$187.88

+6.91%

Biotechnology$25.8BNASDAQ

VRTX

Vertex Pharmaceuticals Inc

$435.1

-4.37%

Biotechnology$119.2BNASDAQ

60-day price, rebased to 100

BIIB +6.64% · VRTX -7.41%

Round-by-round

BIIB 2·VRTX 3· 1tie

EdgeBIIB

Valuation upside

+7.40% vs -43.10% to DCF fair value

EdgeVRTX

Balance-sheet strength

Altman Z 3.10 vs 12.39

Tie

Fundamental quality

Piotroski 6.00 vs 6.00 (of 9)

EdgeVRTX

Growth + margins

Rule-of-40 23.00 vs 35.50

EdgeBIIB

60-day momentum

+6.64% vs -7.41% price return

EdgeVRTX

Market-cap liquidity

$25.8B vs $119.2B

Verdict

Across6categories,VRTXtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onBIIBorVRTX

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.